Wednesday, March 4, 2020

Major Generic Pharmaceutical Company Admits to Antitrust Crimes

U.S. Department of Justice


You are subscribed to Antitrust Press Releases for U.S. Department of Justice. This information has recently been updated, and is now available.

03/02/2020 12:00 AM EST

Sandoz Inc., a generic pharmaceutical company headquartered in New Jersey, was charged for conspiring to allocate customers, rig bids, and fix prices for generic drugs, the Department of Justice announced.  A four-count felony charge was filed today in the United States District Court for the Eastern District of Pennsylvania in Philadelphia, charging Sandoz with participating in four criminal antitrust conspiracies, each with a competing manufacturer of generic drugs and various individuals.  This represents the third pharmaceutical company to admit to criminal antitrust charges in the Antitrust Division's ongoing investigation.  The charged conspiracies took place between 2013 and 2015.
 


No comments:

Page List

Blog Archive

Search This Blog

Never Fear the "October Surprise"

Prepare to buy elite small caps like this one on the next pullback...   October 8, 2024 Note from Ashley Cassell, ...